Does NINTEDANIB Cause Small cell lung cancer? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Small cell lung cancer have been filed in association with NINTEDANIB. This represents 0.1% of all adverse event reports for NINTEDANIB.
28
Reports of Small cell lung cancer with NINTEDANIB
0.1%
of all NINTEDANIB reports
9
Deaths
4
Hospitalizations
How Dangerous Is Small cell lung cancer From NINTEDANIB?
Of the 28 reports, 9 (32.1%) resulted in death, 4 (14.3%) required hospitalization, and 1 (3.6%) were considered life-threatening.
Is Small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NINTEDANIB. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does NINTEDANIB Cause?
Diarrhoea (9,103)
Nausea (4,198)
Dyspnoea (3,080)
Decreased appetite (2,832)
Death (2,790)
Weight decreased (2,628)
Vomiting (2,524)
Fatigue (2,511)
Cough (2,193)
Idiopathic pulmonary fibrosis (1,905)
What Other Drugs Cause Small cell lung cancer?
CARBOPLATIN (74)
TARLATAMAB-DLLE (66)
ETOPOSIDE (65)
ATEZOLIZUMAB (62)
OSIMERTINIB (46)
METHOTREXATE (35)
AFATINIB (30)
ADALIMUMAB (29)
GEFITINIB (28)
TACROLIMUS (28)
Which NINTEDANIB Alternatives Have Lower Small cell lung cancer Risk?
NINTEDANIB vs NINTEDANIB ESYLATE
NINTEDANIB vs NIRAPARIB
NINTEDANIB vs NIRMATRELVIR\RITONAVIR
NINTEDANIB vs NIROGACESTAT
NINTEDANIB vs NIROGACESTAT HYDROBROMIDE